Company Filing History:
Years Active: 2000-2001
Title: **Georg Stoll: Innovator in Pharmaceutical Compositions**
Introduction
Georg Stoll is a prominent inventor based in Freiburg, Germany. With a significant contribution to the field of pharmaceuticals, he holds two patents that showcase his innovative approach. His work primarily focuses on developing polymeric matrices which have critical applications in medical treatments.
Latest Patents
Georg Stoll's latest patents revolve around "Polymeric matrices and their uses in pharmaceutical compositions." This invention provides pharmaceutical compositions containing polymeric matrices that include IL-6 as an active ingredient. Specifically, he has developed novel poly(ethylene carbomate) polymers that serve as effective matrix materials for sustained release compositions with pharmacologically active compounds. These innovations also detail methods to utilize IL-6 in treating various conditions mediated by IL-1 and/or TNF-alpha, such as certain autoimmune and inflammatory conditions, as well as septic shock.
Career Highlights
Currently, Georg Stoll is associated with Novartis AG, a leading pharmaceutical company known for its commitment to research and innovation. His career is marked by a dedication to advancing pharmaceutical technology and improving patient outcomes through his groundbreaking inventions.
Collaborations
Throughout his career, Georg has collaborated with notable colleagues, including Murat Acemoglu and Siegfried Bantle. These collaborations reflect his commitment to teamwork and advancing scientific knowledge within the pharmaceutical industry.
Conclusion
Georg Stoll's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a key inventor. His work continues to make a significant impact on the development of pharmaceutical compositions, ultimately aiming to enhance therapeutic solutions for complex health conditions.